Company intelligence / Profile preview

Phapros

Jakarta Selatan, DKI Jakarta, Indonesia

Ownership: Private
Employees: ~1384
Development stage: Other

Overview

Phapros produces more than 250 medicinal and health products, including branded, ethical, generic, and OTC medicines, and medical devices. Its Antimo motion sickness drug, blood-enhancing tablets, and export products like Fluza tablets have strong market positions[1][2][3][4][5][6][7].

Therapeutic areas: HematologyNeurologyOther
Modalities: Small moleculeBiologicMedical device
Industry: Biotech

Partnerships

BRIN (Indonesian National Research and Innovation Agency)Gajah Mada UniversityRSUD dr. Soetomo (hospital)Other local research/academic institutions

Beyond the preview

Go deeper on Phapros.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phapros.

Explore the full profile